Bruce G. Allen Investments, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Bruce G. Allen Investments, LLC
- $123 Billion
- Q4 2024
A detailed history of Bruce G. Allen Investments, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 27 shares of CPRX stock, worth $609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 27
-0.0%
Holding current value
$609
Previous $537,000
4.84%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
331Shares Held
95.3MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$422 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$181 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$141 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$128 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$68.1 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.32B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...